Fenspiride: Difference between revisions

Fenspiride
Clinical data
Trade names	Eurespal, Pneumorel
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	R03BX01 (WHO) R03DX03 (WHO);
Legal status
Legal status	In general: ℞ (Prescription only);
Pharmacokinetic data
Bioavailability	90%
Elimination half-life	14–16 hours
Excretion	Urine (90%), feces (~10%)
Identifiers
	IUPAC name 8-(2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one;
CAS Number	5053-06-5 ;
PubChem CID	68626;
UNII	S983QC7HKM;
KEGG	D07949 ;
ChEMBL	ChEMBL576127 ;
CompTox Dashboard (EPA)	DTXSID4023048 ;
ECHA InfoCard	100.023.411
Chemical and physical data
Formula	C15H20N2O2
Molar mass	260.331 g/mol g·mol−1
	(what is this?) (verify)

Browse history interactively

← Previous edit Next edit →

Content deleted Content added

VisualWikitext

Inline

Revision as of 16:00, 6 February 2014

Fenspiride (INN, brand names Eurespal, Pneumorel and others) is an oxazolidinone spiro compound used as a drug in the treatment of certain respiratory diseases.^[2] In Russia it is approved for the treatment of acute and chronic inflammatory diseases of ENT organs and the respiratory tract (like rhinopharyngitis, laryngitis, tracheobronchitis, otitis and sinusitis), as well as for maintenance treatment of asthma.^[3]

References

^ Montes, B (1993). "Single dose pharmacokinetics of fenspiride hydrochloride: phase I clinical trial". European journal of clinical pharmacology. 45 (2): 169–72. PMID 7901024. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
^ Płusa T, Nawacka D (1998 Dec). "Efficacy and tolerance of fenspiride in adult patients with acute respiratory tract infections". Pol Merkur Lekarski. 5 (30): 368–71. PMID 10101527. {{cite journal}}: Check date values in: |year= (help)
^ "Эреспал^® (Eurespal^®) Prescribing Information. VIDAL Drug Compendium" (in Russian). Retrieved 6 February 2014.

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

[1] Montes, B (1993). "Single dose pharmacokinetics of fenspiride hydrochloride: phase I clinical trial". European journal of clinical pharmacology. 45 (2): 169–72. PMID 7901024. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)

[2] Płusa T, Nawacka D (1998 Dec). "Efficacy and tolerance of fenspiride in adult patients with acute respiratory tract infections". Pol Merkur Lekarski. 5 (30): 368–71. PMID 10101527. {{cite journal}}: Check date values in: |year= (help)

[PI-3] "Эреспал^® (Eurespal^®) Prescribing Information. VIDAL Drug Compendium" (in Russian). Retrieved 6 February 2014.

[1]

[2]

[3]

@@ Line 5: / Line 5: @@
 | IUPAC_name = 8-(2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one
 | image = Fenspiride.svg
+| width = 200
 | image2 = Fenspiride ball-and-stick animation.gif
 <!--Clinical data-->
-| tradename =
+| tradename = Eurespal, Pneumorel
 | Drugs.com = {{drugs.com|international|fenspiride}}
 | pregnancy_category =
-| legal_status =
+| legal_status = Rx-only
-| routes_of_administration =
+| routes_of_administration = Oral
 <!--Pharmacokinetic data-->
+| bioavailability = 90%<ref>{{cite journal|last=Montes|first=B|coauthors=Catalan, M; Roces, A; Jeanniot, JP; Honorato, JM|title=Single dose pharmacokinetics of fenspiride hydrochloride: phase I clinical trial.|journal=European journal of clinical pharmacology|date=1993|volume=45|issue=2|pages=169–72|pmid=7901024}}</ref>
-| bioavailability =
 | metabolism =
-| elimination_half-life =
+| elimination_half-life = 14–16 hours
-| excretion =
+| excretion = Urine (90%), feces (~10%)
 <!--Identifiers-->
@@ Line 39: / Line 40: @@
 }}
-'''Fenspiride''' ([[International Nonproprietary Name|INN]], brand name '''Pneumorel''') is a [[spiro compound]] used as a drug in the treatment of certain respiratory diseases.<ref>{{cite journal |title = Efficacy and tolerance of fenspiride in adult patients with acute respiratory tract infections |author = Płusa T, Nawacka D |journal = Pol Merkur Lekarski |year = 1998 Dec |volume =5 |pages = 368–71 |pmid=10101527 |issue=30}}</ref>
+'''Fenspiride''' ([[International Nonproprietary Name|INN]], brand names '''Eurespal''', '''Pneumorel''' and others) is an oxazolidinone [[spiro compound]] used as a drug in the treatment of certain respiratory diseases.<ref>{{cite journal |title = Efficacy and tolerance of fenspiride in adult patients with acute respiratory tract infections |author = Płusa T, Nawacka D |journal = Pol Merkur Lekarski |year = 1998 Dec |volume =5 |pages = 368–71 |pmid=10101527 |issue=30}}</ref> In Russia it is approved for the treatment of acute and chronic inflammatory diseases of ENT organs and the respiratory tract (like rhinopharyngitis, laryngitis, tracheobronchitis, otitis and sinusitis), as well as for maintenance treatment of [[asthma]].<ref name=PI>{{cite web|title=Эреспал<sup>®</sup> (Eurespal<sup>®</sup>) Prescribing Information. VIDAL Drug Compendium|url=http://www.vidal.ru/poisk_preparatov/eurespal~34706.htm|accessdate=6 February 2014|language=Russian}}</ref>
 == References ==
@@ Line 50: / Line 51: @@
 [[Category:Oxazolidinones]]
 [[Category:Spiro compounds]]
 {{respiratory-system-drug-stub}}